Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity by Wojciech Ornatowski et al.
Research article
	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 117      Number 11      November 2007  3489
Elevated furin levels in human cystic fibrosis 
cells result in hypersusceptibility  
to exotoxin A–induced cytotoxicity
Wojciech Ornatowski,1 Jens F. Poschet,1 Elizabeth Perkett,2,3  
Jennifer L. Taylor-Cousar,3,4 and Vojo Deretic1,2
1Department of Molecular Genetics and Microbiology, 2Department of Cell Biology and Physiology,
 
3Department of Pediatrics, and  

















































































































































Furin levels are elevated in CF cells. Furin activity was 
measured by monitoring cleavage of fluorogenic substrate 
boc-RVRR-amc in extracts from lung epithelial cells. One 
unit of activity was defined as the amount of enzyme 
required to liberate 1 pmol of AMC from boc-RVRR-amc. 
(A) IB3-1, pCEP-R, and CFBE (all 3 cell lines with a CF 
phenotype) and S9, pCEP, and 16HBE (all 3 cell lines with 
CFTR-corrected or non-CF phenotype). (B) Furin activity 
in primary human (CF and normal) lung epithelial cells 
measured in the presence or absence of the furin inhibi-
tor CMK. (C) Furin western blot and densitometry analy-
sis. (D) Human lung epithelial cells after treatment with 
furin inhibitors CMK and α1-PDX. Production of TGF-β 
was measured in IB3-1 (CF) and S9 (CFTR corrected) 
epithelial cells using TGF-β–responsive luciferase assay. 
CMK, 50 μM; α1-PDX, 5 μM. Data are presented as per-
centage of furin or TGF-β, for which 100% corresponds 
to protein levels in non-CF cells (n = 3 experiments). 
Mean ± SEM (*P < 0.05, **P < 0.01; †P ≥ 0.05).
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TGF-β suppresses antipseudomonal action of macrophages and dimin-
























Chloroquine and blocking antibodies against TGF-β normalize furin 
activity in CF cells. Cells were incubated in full medium with 10 ng/ml 
TGF-β1 or in the presence of 5 μg/ml TGF-β antibodies or were treat-
ed with 0.1 mM chloroquine (CQ). (A) IB3-1 (CF) and S9 (CFTR cor-
rected) cells. (B) pCEP-R (overexpressing the CFTR R domain) and 
pCEP (mock-transfected) cells. (C) CFBE (CF) and 16HBE (normal) 
cell lines. (D) Additionally, furin levels were normalized with 100 nM 
bafilomycin A1 (BA) or 50 μM furin inhibitor (CMK) in primary (CF and 
normal) human lung epithelial cells. Data are presented as percent-
age of furin, where 100% corresponds to furin activity in non-CF cells 
(n = 3 experiments). Mean ± SEM (*P < 0.05, **P < 0.01).
Figure 3
TGF-β contributes to increased collagen production. (A) Total soluble 
collagen (%) was measured in the media from human airway epithelial 
cells after 24 hours. Media containing collagen from non-CF (open 
bars) and CF (filled bars) cell lines. (B) IB3-1 cells incubated in full 
medium with 5 μg/ml blocking TGF-β antibodies in the presence of 
furin inhibitor (α1-PDX) or treated with 0.1 mM chloroquine. 100% cor-
responds to collagen levels in non-CF cells. Mean ± SEM (n = 3 experi-
ments; **P < 0.01).
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CF cells are more sensitive to P. aeruginosa ExoA. ExoA is detectable 


























































CF cells are more sensitive to P. aeruginosa 
ExoA. CF and matched non-CF respiratory 
epithelial cells were cultured overnight in 
96-well plates with media containing 10% 
serum. Cells were incubated with ExoA for 
24 hours. Cell viability was measured by 
adding WST-1 as described in Methods. 
(A) AS1 normal human respiratory epithelial 
cells stably transfected with CFTR antisense 
construct (inducing CF phenotype) and their 
matching control S1 (cells stably transfect-
ed with the sense construct). (B) pCEP-R 
(overexpressing the dominant-negative 
CFTR R domain) and pCEP (mock-trans-
fected). (C) IB3-1 and S9 (CFTR corrected). 
Human lung epithelial cells were incubated 
with furin inhibitor CMK (50 μM) for 24 hours 
at 37°C. (D) Dose-dependent cytotoxicity of 
ExoA. Lung epithelial cells were treated for 
24 hours with increasing concentrations of 
P. aeruginosa ExoA (0 to 3,000 ng/ml). Data 
are presented as percentage of live cells, for 
which 100% corresponds to ExoA untreat-
ed cells (n = 3 experiments). Mean ± SEM 
(*P < 0.05, **P < 0.01, †P ≥ 0.05).
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CF cells show increased sensitivity to 
ExoA inhibition of protein synthesis. 
CF and non-CF cells were incubated 
in media containing either increasing 
concentrations of ExoA for 24 hours 
(A) or 100 ng ExoA/ml (B) with IB3-1 
and S9 (CFTR-corrected) cells. (C) CF 
primary lung epithelial cells in the pres-
ence or absence of furin inhibitor CMK 
(50 μM) or treated with 100 nM bafilo-
mycin A1 (BA). Protein synthesis lev-
els were determined by measuring the 
incorporation of [3H] leucine into TCA-
precipitable cellular proteins and are 
expressed as percentage of control cells 
that received no toxin. Mean ± SEM 
for 3 separate experiments; *P < 0.05, 
**P < 0.01, †P ≥ 0.05.
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The most surprising aspect of our study  is  the  finding that 
P. aeruginosa toxin ExoA causes significantly higher cell death in CF 
Figure 6
Furin-dependent processing of ExoA is increased in 
CF cells. (A) Localization of ExoA in CFTR mutant 
IB3-1 cells by fluorescence microscopy (insets, 
close apposition). Cells were transfected with GFP-
furin or cellubrevin-pHluorin GFP and incubated 
with ExoA conjugated to secondary Alexa Fluor 568 
(red). EEA1 was visualized using primary human 
anti-EEA1 antibody and Alexa Fluor 468–conjugated 
antibody (green). Scale bars: 5 μm; 2 μm (insets). 
(B) SDS-PAGE analysis of ExoA processing in IB3-1 
(CFTR mutant) cells, IB3-1 cells incubated with CMK 
(50 μM), and S9 (CFTR-corrected IB3-1) cells. Pro-
teins in cell extracts were separated by SDS-PAGE 
and immunoblotted with anti-ExoA. ExoA66, full 
size, inactive ExoA toxin precursor; ExoA37, proteo-
lytically processed 37-kDa active ExoA fragment. 
(C) Densitometry analysis of ExoA66/ExoA37 ratio.
research article




























































































Model depicting pathological cascade in CF based on increased furin activity and ele-
vated TGF-β levels. Low intra-organellar (TGN and recycling endosome) pH in CF cells 
increases furin activity in respiratory epithelial cells, which causes a cascade of down-
stream effects. Left: Increased TGF-β maturation due to its enhanced processing con-
tributes to suppression of iNOS and increased secretion of fibrotic tissue components 
(collagen). Increased TGF-β further augments furin levels in a positive feedback loop. 
Increased TGF-β leads to tissue fibrosis contributing to bronchiectasis, and local immu-
nosuppression. Right: Increased activation of P. aeruginosa ExoA by furin in the TGN 
leads to higher cytotoxicity. These defects underlie the majority of salient aspects of lung 
disease in CF.
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